Successful ligelizumab treatment of severe refractory solar urticaria.
Hershkovitz Y, Khanimov I, Rubin L, Dranitzki Z, Talmon A, Ribak Y, Shamriz O, Levi A, Tal Y.
Hershkovitz Y, et al. Among authors: khanimov i.
J Allergy Clin Immunol Pract. 2023 Aug;11(8):2576-2577. doi: 10.1016/j.jaip.2023.01.052. Epub 2023 Feb 15.
J Allergy Clin Immunol Pract. 2023.
PMID: 36796509
No abstract available.